Valera Pharmaceuticals Sets Date for Reporting First-Quarter 2006 Financials; Company to Present at UBS and Fortis Conferences.CRANBURY, N.J. -- Valera Pharmaceuticals (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : VLRX) today said it will report its first-quarter 2006 financial results on Thursday morning, April 27, 2006. The Company will conduct a conference call on April 27, 2006, at 8:30 a.m. ET to discuss its financial results and progress with respect to certain milestones. The conference call will be available via phone at 1-800-289-0494 and via webcast which can be accessed through the Media Center or Investor pages of Valera's corporate website at www.valerapharma.com. Please dial-in or login to the conference call several minutes prior to start time. A replay of the quarterly conference call will be available via the webcast link through May 5, 2006. Valera also noted that its President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , David S. Tierney, M.D. is scheduled to present at the UBS UBS Union Bank of Switzerland UBS United Bible Societies UBS United Blood Services UBS United Buying Service UBS Used Bookstore UBS University Business Services UBS Universal Building Society (UK) UBS Ulaanbaatar Broadcasting System 2006 Global Specialty Pharmaceuticals Conference in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. on April 24, 2006 at 10:00 a.m. ET. UBS will webcast the audio portion of the Company's presentation which will be available live and by replay via the Valera corporate website. The replay will begin three hours after the live presentation time, and will remain on the Valera website through May 5, 2006. The UBS Global Specialty Pharmaceuticals Conference will be held at the Grand Hyatt New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of , Park Avenue at Grand Central in New York on April 24-25, 2006. Dr. Tierney will also present at the 6th Annual Fortis Bank Biotechnology Conference in London on April 26, 2006 at 10:00 a.m. UK time. The Fortis Bank Biotechnology Conference will be held on April 26, 2006 at the Four Seasons Hotel, Hamilton Place, Park Lane, London. About Valera Pharmaceuticals Valera Pharmaceuticals is a specialty pharmaceutical company engaged in the development, acquisition, and commercialization of products to treat urology and endocrinology diseases and disorders. VANTAS(R), a patent protected once-per-year implant that utilizes the Company's Hydron implant technology, is currently marketed by Valera for the palliative treatment palliative treatment n. Treatment to alleviate symptoms without curing the disease. Palliative treatment A type treatment that does not provide a cure, but eases the symptoms. Mentioned in: Laparoscopy of advanced prostate cancer prostate cancer, cancer originating in the prostate gland. Prostate cancer is the leading malignancy in men in the United States and is second only to lung cancer as a cause of cancer death in men. . |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion